Glimepiride 1 mg + Voglibose 0.2 mg + Metformin Hydrochloride (SR) 500 mg Tablets
Description:
Glimiford MV-1 is a triple combination antidiabetic tablet designed to provide comprehensive glycemic control in patients with Type 2 Diabetes Mellitus. It combines three powerful agents:
Glimepiride (1 mg): Enhances insulin secretion from pancreatic -cells
Metformin SR (500 mg): Reduces hepatic glucose output and increases insulin sensitivity
Voglibose (0.2 mg): Slows carbohydrate absorption and controls postprandial blood sugar spikes
Key Benefits:
Controls both fasting and postprandial blood glucose
Improves insulin response and reduces glucose load
Convenient once/twice daily dosing with improved adherence
Lower risk of hypoglycemia compared to monotherapy
Indications:
Type 2 Diabetes Mellitus (when diet, exercise, and dual therapy are not sufficient)
Ideal for patients with high post-meal glucose levels
Price: